Web Results
Darifenacin Highlights
DARIFENACIN (dar ee FEN a sin) is used to treat overactive bladder. This medicine reduces the amount of bathroom visits. It may also help to control wetting accidents. More »
Source: healthline.com

en.wikipedia.org/wiki/Darifenacin

Darifenacin is a medication used to treat urinary incontinence. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier ...

www.webmd.com/drugs/2/drug-92490/darifenacin-oral/details

Find patient medical information for Darifenacin Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

www.drugs.com/cdi/darifenacin-extended-release-tablets.html

Easy to read patient leaflet for darifenacin extended-release tablets. Includes indications, proper use, special instructions, precautions, and possible side effects.

www.rxlist.com/enablex-drug.htm

ENABLEX ® (darifenacin) Tablets. DESCRIPTION. Enablex is an extended- release tablet for oral administration which contains 7.5 mg or 15 mg darifenacin as ...

medlineplus.gov/druginfo/meds/a605039.html

Jun 15, 2016 ... Darifenacin: learn about side effects, dosage, special precautions, and more on MedlinePlus.

reference.medscape.com/drug/enablex-darifenacin-342850

Medscape - Indication-specific dosing for Enablex (darifenacin), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

www.drugbank.ca/drugs/DB00496

Darifenacin works by blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions. It thereby decreases the ...

www.emedicinehealth.com/drug-darifenacin/article_em.htm

Drug information on Enablex (darifenacin), includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.

www.healthline.com/drugs/darifenacin/oral-tablet

Darifenacin is an oral medication used to treat the symptoms of overactive bladder. Learn about side effects, warnings, dosage, and more.